Tetracycline and trimethoprim/sulfamethoxazole at clinical laboratory: can they help to characterize Staphylococcus aureus carrying different SCCmec types?

INTRODUCTION Methicillin-resistant Staphylococcus aureus (MRSA) can be difficult to detect at the clinical practice. METHODS We analyzed 140 MRSA isolates from inpatients to correlate the antimicrobial susceptibility with the SCCmec types. RESULTS Type III (n = 63) isolates were more resistant to ciprofloxacin, clindamycin, cloramphenicol, erythromycin, gentamicin, and rifampin than type IV (n = 65) ones (p < 0.05). Moreover, type IV isolates were susceptible to tetracycline (100%) and trimethoprim/sulfamethoxazole (98%), while type III isolates presented resistance to them. CONCLUSIONS In regions where these SCCmec types are prevalent, the detection of specific resistant phenotypes could help to predict them, mainly when there are no technical conditions to SCCmec typing.

[1]  N. Saunders,et al.  Rapid extraction of bacterial genomic DNA with guanidium thiocyanate , 1989 .

[2]  F. Rossi,et al.  Prevalence of SCCmec Type IV in Nosocomial Bloodstream Isolates of Methicillin-Resistant Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[3]  G. Sensabaugh,et al.  Clonal Composition of Staphylococcus aureus Isolates at a Brazilian University Hospital: Identification of International Circulating Lineages , 2006, Journal of Clinical Microbiology.

[4]  M. Ramos,et al.  Changes in the Clonal Nature and Antibiotic Resistance Profiles of Methicillin-Resistant Staphylococcus aureus Isolates Associated with Spread of the EMRSA-15 Clone in a Tertiary Care Portuguese Hospital , 2007, Journal of Clinical Microbiology.

[5]  H. de Lencastre,et al.  Update to the Multiplex PCR Strategy for Assignment of mec Element Types in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[6]  J. Ruhe,et al.  Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[7]  J. Patel,et al.  Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  Teruyo Ito,et al.  Type IV SCCmec found in decade old Brazilian MRSA isolates. , 2008, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[9]  S. Nouér,et al.  Polyclonal presence of non-multiresistant methicillin-resistant Staphylococcus aureus isolates carrying SCCmec IV in health care-associated infections in a hospital in Rio de Janeiro, Brazil. , 2009, Diagnostic microbiology and infectious disease.

[10]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[11]  L. A. Teixeira,et al.  Emergence of multiresistant variants of the community-acquired methicillin-resistant Staphylococcus aureus lineage ST1-SCCmecIV in 2 hospitals in Rio de Janeiro, Brazil. , 2009, Diagnostic microbiology and infectious disease.

[12]  J. Karlowsky,et al.  Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008. , 2010, Diagnostic microbiology and infectious disease.